|
Bayer acquires exclusive rights to Bioton's insulin SciLin®
|
10 July 2009 |
|
Bayer submits first-in-class estradiol-based oral contraceptive for approval in the US
|
09 July 2009 |
|
Bayer files patent infringement lawsuit against Teva
|
02 July 2009 |
|
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
|
30 June 2009 |
|
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Non-small Cell Lung Cancer
|
02 June 2009 |
|
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Non-small Cell Lung Cancer
|
02 June 2009 |
|
Phase III Trial Started to Evaluate Combination Therapy of Nexavar® and Tarceva®
|
29 May 2009 |
|
Nexavar® Approved in Japan for the Treatment of Advanced Liver Cancer
|
21 May 2009 |
|
Qlaira® - innovative estradiol-based oral contraceptive available in Europe
|
15 May 2009 |
|
Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch
|
07 May 2009 |
|
Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors
|
30 April 2009 |
|
Bayer Crop Science and the French research organization CNRS intensify collaboration
|
31 March 2009 |
|
New image of therapy for erectile difficulties
|
20 March 2009 |
|
Advances in Renal Cancer Journalists' Award
|
27 February 2009 |
|
Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center
|
12 February 2009 |
|
Bayer innovations provide solutions for the global challenges of the future
|
15 December 2008 |
|
Bayer Schering Pharma expands men's healthcare portfolio
|
05 December 2008 |
|
Bayer's Xarelto® Shows Encouraging Results in Patients with Acute Coronary Syndrome
|
11 November 2008 |
|
European Journalists' Prize 2008 announced by Bayer HealthCare
|
14 October 2008 |
|
Bayer Reports Progress in Clinical Program for Riociguat
|
06 October 2008 |